Patent Oppositions in material property testing industry

Explore the competitive field of material property testing where companies are constantly innovating to stay ahead. Discover the latest patent opposition trends, top companies filing and facing patent oppositions, and the most recent patents under dispute. Stay informed on patent activity in material property testing technology and learn how to protect your intellectual property.

Explore the top companies that have filed the most patent oppositions in the technology industry.

Explore the top companies that have faced the most patent oppositions in the technology industry.

Explore the top law firms that have filed the most patent oppositions in the technology industry.

Patent challenges are becoming increasingly common in the material property testing industry as companies work to protect their innovations in a highly competitive market. These legal battles can significantly impact the development and release of new technologies. Below is a list of the latest patents that have been opposed in the material property testing industry, offering a snapshot of the ongoing struggles over intellectual property rights. For anyone involved in this industry, understanding these patent disputes is essential for navigating its future.

Last updated on: Sep 10, 2026
Patent NumberTitleApplicantOpposition DateOpposition Name
Monitoring Performance In Continuous ChromatographyGE HEALTHCARE BIO SCIENCESSep 3, 2026NIERFELD
A Package Quality Inspection Station And A Method For Inspecting Quality Of A PackageTETRA LAVAL & FINANCESep 3, 2026HEUFT SYSTEMTECHNIK
Separation Of Oligosaccharides From Fermentation BrothGLYCOMAug 25, 2026CHR HANSEN HMO
Separation Of Oligosaccharides From Fermentation BrothGLYCOMAug 24, 2026GREAVES BREWSTER
Systems And Methods For Chromatography Use And RegenerationREGENERON PHARMACEUTICALSAug 18, 2026BOULT WADE TENNANT
Compositions And Methods For Analyte DetectionPRESIDENT AND FELLOWS OF HARVARD COLLEGEAug 7, 2026ELEMENT BIOSCIENCES NETHERLANDS B.V.
Method Of Treating Cancer Using Immune Checkpoint Inhibitor; Antibody That Binds To Programmed Death-1 Receptor (Pd-1) Or Programmed Death Ligand 1 (Pd-L1)BRISTOL MYERS SQUIBBJul 29, 2026STORZ
Method Of Treating Cancer Using Immune Checkpoint Inhibitor; Antibody That Binds To Programmed Death-1 Receptor (Pd-1) Or Programmed Death Ligand 1 (Pd-L1)BRISTOL MYERS SQUIBBJul 28, 2026DEVA HOLDING
Method Of Treating Cancer Using Immune Checkpoint Inhibitor; Antibody That Binds To Programmed Death-1 Receptor (Pd-1) Or Programmed Death Ligand 1 (Pd-L1)BRISTOL MYERS SQUIBBJul 27, 2026GREINER
Method Of Treating Cancer Using Immune Checkpoint Inhibitor; Antibody That Binds To Programmed Death-1 Receptor (Pd-1) Or Programmed Death Ligand 1 (Pd-L1)BRISTOL MYERS SQUIBBJul 17, 2026POHLMAN

To stay ahead in the competitive material property testing industry, companies are constantly innovating. Here are the top patents facing oppositions in the material property testing industry. Stay informed on the latest opposition trends and learn how to protect your intellectual property.

Last updated on: Sep 10, 2026
Patent NumberPublication DateTitleApplicantTotal Oppositions
Aug 24, 2022Compositions And Uses For Treating Multiple SclerosisBIOGEN IDEC MA15
Sep 19, 2018Methods Of Cell CultureMOMENTA PHARMACEUTICALS10
Oct 29, 2025Method Of Treating Cancer Using Immune Checkpoint Inhibitor; Antibody That Binds To Programmed Death-1 Receptor (Pd-1) Or Programmed Death Ligand 1 (Pd-L1)BRISTOL MYERS SQUIBB9
Jan 13, 2021Method Of Treating Cancer Using Immune Checkpoint InhibitorBRISTOL MYERS SQUIBB9
Nov 19, 2014Determining And Localizing Mold Infestation In Interior SpacesFHRER8
Apr 24, 2024Methods For Treating Atopic Dermatitis By Administering An Il-4R AntagonistSANOFI BIOTECHNOLOGY7
Oct 19, 2016Composition For Inducing Proliferation Or Accumulation Of Regulatory T CellsTHE UNIVERSITY OF TOKYO6
Mar 28, 2018Antigen-Binding Molecule Capable Of Binding To Two Or More Antigen Molecules RepeatedlyCHUGAI SEIYAKU KABUSHIKI KAISHA6
Oct 4, 2023Il-17 A/F Heterologous Polypeptides And Therapeutics Uses ThereofNOVARTIS6
Feb 10, 2016Compositions And Methods Of Identifying Tumor Specific NeoantigensDANA FARBER CANCER INSTITUTE5